During the last session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 0.26 million, with the beta value of the company hitting 1.99. At the end of the trading day, the stock’s price was $2.37, reflecting an intraday gain of 3.04% or $0.07. The 52-week high for the CDT share is $2707.50, that puts it down -114140.51 from that peak though still a striking 5.91% gain since the share price plummeted to a 52-week low of $2.23. The company’s market capitalization is $1.79M, and the average intraday trading volume over the past 10 days was 0.23 million shares, and the average trade volume was 339.52K shares over the past three months.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Conduit Pharmaceuticals Inc (CDT) registered a 3.04% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.04% in intraday trading to $2.37, hitting a weekly high. The stock’s 5-day price performance is -6.32%, and it has moved by -58.42% in 30 days. Based on these gigs, the overall price performance for the year is -99.91%. The short interest in Conduit Pharmaceuticals Inc (NASDAQ:CDT) is 55709.0 shares and it means that shorts have 0.64 day(s) to cover.
CDT Dividends
Conduit Pharmaceuticals Inc is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
Conduit Pharmaceuticals Inc insiders own 18.39% of total outstanding shares while institutional holders control 3.63%, with the float percentage being 4.45%. BARCLAYS PLC is the largest shareholder of the company, while 41.0 institutions own stock in it. As of 2024-06-30, the company held over 0.81 million shares (or 0.0015% of all shares), a total value of $0.86 million in shares.
The next largest institutional holding, with 0.69 million shares, is of BLACKROCK INC.’s that is approximately 0.0012% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.73 million.
